News FDA advisors split on Biogen’s ALS therapy But unanimous vote on biomarker validity could support accelerated approval of tofersen.
News Novartis pulls plug on landmark UK cholesterol trial ORION-17 study has been abandoned, with Novartis opting instead for a smaller global trial.
News Rapid UTI tests could cut antibiotic resistance, says NICE Rapid urine tests could help NHS ensure that antibiotics are used appropriately.
News Roche, Lilly join forces on blood test for Alzheimer’s If approved, EAPP could help streamline the journey to diagnosis for patients, say partners.
News MHRA unveils big shakeup in UK clinical trials regs Reforms will make applications streamlined and flexible without affecting safety, says agency.
News CDC mulls digital health app to support workforce Agency is looking for a subscription-based service that provide digital mental health support.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
